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Available online 30 August 2015AbstractObjectives: The purpose of this study was to investigate the mortality rate and other associated risk factors a year after diagnosis of osteoporotic
hip fracture.
Methods: A prospective cohort study was carried out in 120 patients who were at least 50 years of age who presented with a hip fracture caused
by a simple fall and were admitted to Police General Hospital in 2013. Background data, mortality rate and associated risk factors were collected
and evaluated.
Results: There were 88 females (73.33%) and 32 males (26.67%). The average age was 79.4 years. Eleven patients were deceased by the end of
this study. The mortality rate was about 3.3 times higher when compared to the general population in the same age range (9.2% vs 2.28%). The
survival rates for both sexes at 6 weeks, 6 months and 12 months after fracture were 94.2%, 93.3% and 90.8%, respectively. Higher mortality was
associated with non-operative treatment only. Patients who were treated non-operatively had a 3.93 times higher mortality risk when compared to
those who were treated operatively (23.8% vs 6.1%).
Conclusions: This study shows that the one-year mortality rate of osteoporotic hip fracture patients who were 50 years or older was 9%.
However, the rate increased after an osteoporotic hip fracture, especially within the first year post-fracture. Higher mortality was associated with
non-operative treatment only while the other variables were not.
Copyright © 2015 The Korean Society of Osteoporosis. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Osteoporosis fractures occur in approximately 2% of Thai
women each year [1]. An average incidence of hip fractures is
7.05 per 100,000 annually. Hip fracture is a common serious
injury that affect mainly elderly patients. The incidence of hip
fractures increases with increasing age [2]0.20% of patients
die within the first year after a hip fracture [3], and one in four
elderly patients require a higher level of long-term care after a* Corresponding author. Tel.: þ66 22535836.
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ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).hip fracture [3,4]. The mortality rate during hospitalization
was 2.1%. The 3-, 6-, and 12-month survival rates after hip
fractures were 91%, 88% and 83%, respectively [5].
The purpose of the study was to examine the 1-year mor-
tality rate after osteoporotic hip fracture and also to study
other associated risk factors, which include gender, age, BMI,
fracture sites, and fracture treatment.2. Methods
A prospective cohort of the study was conducted from
January 1st to December 31st 2013 with a sample size of 120
patients who sustained hip fractures and were admitted to the
Police General Hospital during the research period.hosting by Elsevier B.V. This is an open access article under the CC BY-NC-
Table 1
General demographics data of osteoporotic hip fracture patients.
Characteristic Number (%)
Age (y)
80 68 (57%)
>80 52 (43%)
Sex
Male 32 (26.67%)
Female 88 (73.33%)
Parenteral hip fracture (case) 3 (2.5%)
Previous fracture (case) 12 (10.00%)
Hip 10 (8.33%)
Spine 1 (0.83%)
Proximal humerus 1 (0.83%)
Location of fracture (case)
Femoral neck 55 (45.83%)
Intertrochanter 63 (52.5%)
Subtrochanter 2 (1.67%)
Type of treatment (Case)
Operation
[femoral neck/trochanter]
99 (82.5%) [46/53]
Non operation [femoral
neck/trochanter]
21 (17.5%) [9/12]
Type of operation (case)
Fixation 56 (56.57%)
- Proximal femoral nail
antirotation (PFNA)
41 (41.41%)
- Dynamic hip screw (DHS) 10 (10.10%)
- Multiple screw 3 (3.03%)
- Locking plate 1(1.01%)
- Angle blade plate 1 (1.01%)
Arthroplasty 43 (43.43%)
- Hemiarthroplasty 39 (39.39%)
- Total hip arthroplasty 4 (4.04%)
BMD investigation (case)
Pre fracture 8 (6.67%)
Post fracture 34 (28.33%)
Hospitalization (day)
Operative Average 23.16 (Max 69:Min 6)
Non-operative Average 25.86 (Max 102:Min 5)
Time to surgery (day)
Fixation Average 7.896 (Max 33:Min 1)
Arthroplasty Average 7.853 (Max 24:Min 1)
Osteoporotic drug (case)
Calcium and Vitamin D 25 (20.83%)
Antiresorptive agents 18 (15%)
Anabolic agent 6 (5%)
Underlying disease
Hypertension 84 (70%)
Dyslipidemia 33 (27.5%)
Diabetes mellitus 21 (17.5%)
Outcome (case)
Death 11 (9.17%)
Alive 109 (90.83%)
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run general 800-bed hospital and tertiary trauma center. The
location is in the city center of Bangkok, Thailand. This
hospital provides care to all patients, Thai and foreign, and is
fully accessible to the general population in Thailand and
offers all the standard medical services expected from an
accredited national medical facility.
The study's inclusion criteria was restricted to male and
female patients at least 50 years of age with a hip fracture at
either femoral neck, intertrochanteric or subtrochanteric lo-
cations, with the fracture being caused by a simple fall.
Exclusion criteria included secondary osteoporosis, severe
accidents such as a traffic accident and fractures caused by
cancer. Information regarding age, gender, parenteral hip
fracture, previous fracture, fracture sites, fracture treatment,
type of operation, previous BMD, hospitalization periods,
underlying disease, outcome and osteoporotic medications
were obtained from the hospital record. Information in regards
to outpatient visits were carried out through their 6 weeks, 6
months and 12 months post-injury visits. In the case that a
patient did not come for the follow up appointment at the
outpatient clinic, we contacted either the patient directly or the
patient's relatives by telephone. Mortality was identified by
telephone interview and from the Thailand Civil Registration
Office database. 90% of the patients who missed follow up
were successfully contacted by phone and data was obtained
as to whether they were deceased or still alive. If we could not
contact them within one month of their scheduled follow up
date, we checked the Thailand civil registration office database
to see whether or not they were deceased.
Statistical analysis was performed using Stata software
version 12.0. Continuous data were presented as mean and
standard deviation. Categorical data were presented as pro-
portion. The KaplaneMeier test was used to estimate survival
rate and log-rank test was used to compare two survival curve.
The Cox proportional hazards model was used to determine
the relationship between potential associated factors and
mortality. The relative risk test and 95% CI were used to select
associated factors.
3. Results
The demographics of patients who met the eligibility
criteria are summarized in Table 1. There were 88 females
(73.33%) and 32 males (26.67%) included in this study. The
average age was 79.4 years (female, 79.76 yr; male, 78.4 yr).
In terms of age, 52 patients (43%) were over 80 years of age.
In terms of location of fracture, 55 patients (45.83%) had a
femoral neck fracture, 63 patients (52.5%) had an inter-
trochanteric fracture and 2 patients (1.67%) had a sub-
trochanteric fracture. Twelve (10.00%) patients had previous
fractures, with 10 patients (8.33%) having had previous hip
fracture, 1 patient (0.83%) with previous spine fracture and 1
patient (0.83%) with previous proximal humeral fracture.
Three patients had a parenteral hip fracture. In terms of
treatment, 99 patients (82.5%) underwent operative treat-
ment, whereas the remainder 21 patients (17.5%) weretreated non-operatively. The most common reason for non-
operative treatment was severe underlying medical condi-
tions such as congestive heart failure, myocardial infarction,
complicated pneumonia, renal failure and large infected
bedsores, which were present in 70% of the patients who
were treated non-operatively. The remaining 30% who were
treated non-operatively was from either the patient or the
patient relatives denying treatment. Operative treatment was
either by fixation or arthroplasty. Forty-one cases (41.41%)
received proximal femoral nail antirotation (PFNA) fixation,
Table 3
Mortality rate of osteoporotic hip fracture by Associated risk factors (relative
risk).
Characteristics Number Mortality Relative
risk
95% CI (P)
N %
Age (y)
80 68 6 8.8 1
>80 52 5 9.6 1.09 0.35 to 3.38 (0.88)
Sex
Male 32 3 9.4 1
Female 88 8 9.1 0.97 0.27 to 3.43 (0.96)
BMI
<18.5 17 2 11.8 1
18.5e22.9 61 5 8.2 0.70 0.15 to 3.28 (0.65)
23e29 37 3 8.1 0.69 0.13 to 3.75 (0.66)
>29 5 1 20.0 1.70 0.19 to 15.09 (0.64)
Fracture sites
Intertrochanteric 63 5 7.9 1
Subtrochanteric 2 0 0.0 1
Femoral neck 55 6 10.9 1.37 0.44 to 4.26 (0.58)
Fracture treatments
Operative 99 6 6.1 1
Non-operative 21 5 23.8 3.93 1.32 to 11.68 (0.01)
BMI: body mass index.
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three cases (3.03%) received multiple screw fixation, one
case (1.01%) received locking plate fixation and one case
(1.01%) was treated by angle blade plate fixation. In the
cases treated by arthroplasty, 39 cases (39.39%) underwent
hemiarthroplasty and 4 cases (4.04%) were treated by total
hip arthroplasty. The time leading up to surgery was divided
into 2 groups, with an average of 7.896 days (Max 33, Min 1)
in the fixation group and an average of 7.853 days (Max 24,
Min 1) in the arthroplasty group. The average length of
hospitalization was 23.63 days, being 23.16 days if the pa-
tient had undergone operative treatment and 25.86 days if
non-operative treatment was used. In terms of pharmaco-
logical osteoporotic treatment, 25 patients (20.83%) received
calcium and vitamin D supplementation, 18 patients (15%)
received antiresorptive agents and 6 patients (5%) received
an anabolic agent.
The most common chronic illnesses were hypertension in
84 patients (70%), dyslipidemia in 33 patients (27.5%) and
diabetes mellitus in 21 patients (17.5%). Eleven (9.17%) pa-
tients had passed away by the end of this study whereas 109
patients (90.83%) were still alive. Overall mortality rate (cu-
mulative number of deaths) is given separately in Table 2:
during hospitalization, n ¼ 5 (4.2%); at 6 weeks, n ¼ 7
(5.8%); at 6 months, n ¼ 8 (6.7%) and at 12 months (end of
follow-up), n ¼ 11 (9.2%).
The mortality rates according to age, gender, BMI, fracture
sites, fracture treatment, and other associated factors are given
separately in Table 3. This study found that only the method of
fracture treatment was associated with higher mortality, while
the other variables had no statistically significant association.
Patients who were treated non-operatively had a mortality risk
3.93 times higher than those who were treated operatively
(23.8% vs 6.1%).
With an exception of when the patients have very severe
underlying morbidity, surgery is still the treatment of choice
for patients with multiple comorbidities. Mortality rate of
patients at one year after operative treatment was 6.1%.
Proximal femoral nails antirotation (PFNA) fixation makes up
41.41% of the operative treatment, with hemiarthroplasty at
39.38% and dynamic hip screws at 10.10%.
The KaplaneMeier survival analysis (Fig. 1) shows sur-
vival rate compared in the two groups of operative and non-
operative treatment, with a significant higher in 1 year sur-
vival rate in the operative group (94% vs 76%) (p-value
0.013).Table 2
Overall mortality (cumulative number of deaths).
Visit Number of Patients Cumulative number
of deaths
N %
Initial visit 120 5 4.2
Follow-up visit 1 (6 wk) 115 7 5.8
Follow-up visit 2 (6 mo) 113 8 6.7
Follow-up visit 3 (12 mo) 112 11 9.2
Total 120 11 9.24. Discussion
In the year 1990, the population over the age of 65 was
estimated to be approximately 323 million, and is expected to
reach 1.555 billion worldwide by 2050 [6]. The number of hip
fractures is expected to increase from 1.7 million in 1990 to
6.25 million in 2025 [6]. Hip fracture is one of the most
common fracture types in the elderly. It frequently requires
costly interventions resulting in functional impairment, loss of
independence, and mortality [7,8]. The postoperative mortality
rate in a year is reported to be at a range from 13% to 36%,
depending on various risk factors. However, the most widely
reported percentage is approximately 25% [9,10].
Chariyalertsaket al. reported that the 1-year mortality rate of
hip fracture patients in Thailand was 17% [5]. In this study, the
1-year mortality rate of hip fracture was 9.2% (male 9.4%,Fig. 1. KaplaneMeier survival estimates in osteoporotic hip fracture (No
operation VS operation).
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(4.2%). In this study, mortality looks substantially lower than
that reported previously. It was possible that this is a single-
center study done in a tertiary trauma center in Bangkok. As
it is a trauma center, the facility has a high standard of care
with well-trained staff as well as attending physicians in every
specialty. The mortality was mostly in patients who were
treated non-operatively, which was shown to be at a rate of
23.8% within the non-operative treatment group, which is
considered a low rate when compared to many other hospitals
in Thailand.
Patients who sustained a hip fracture had a significantly
higher mortality rate in the first year following hip fracture
compared to patients among the same age range without a
fracture [11]. Mortality rate after osteoporotic hip fracture in
patients 50 years of age was approximately 3.3 times higher
than the general population in the same age range (9.2% vs
2.28%). Findings from subgroup analyses by fracture types
showed no differences in mortality or cause of death between
patients with femoral neck, intertrochanteric and sub-
trochanteric fractures. In contrast, a Greek study of 499 hip
fracture patients with trochanteric fracture predominance
(67%) reported higher mortality rate after trochanteric hip
fracture than cervical hip fracture at 5 and 10 years following
the incident [12]. They concluded that the type of hip fracture
was an independent predictor of long-term mortality in hip
fracture patients. On the other hand, a Danish study of 2674
hip fracture patients with cervical hip fracture predominance
(64%) reported that the mortality rates between cervical and
pertrochanteric hip fracture patients were not significantly
different during a mean follow-up of 2.6 years [13].
We found no significant difference in the mortality rate in
different age group, gender and BMI. However, there was a
strong difference in mortality rate between non-operative and
operative treatments. The mortality rate for non-operative
treatment was approximately 3.93 times higher than that of
operative treatment. These results were similar to other studies
that reported a large number of hip fractures [14].
Decreasing the mortality rate for patients with hip fracture
has been a major concern. One method to decrease mortality
rate would be to properly manage the underlying comorbid-
ities of hip fracture patients. The advantages of early surgery
are to decrease pain and improve mobility, which in turn also
decreases pulmonary complications such as atelectasis,
pneumonia and pulmonary thromboembolism [15e18].
In Thailand, due to the high cost of therapy, inadequate
treatment is still an issue. In our study, only 40.83%of patients
received osteoporotic drugs, with 25 cases (20.83%) receiving
calcium and vitamin D supplementation, 18 cases (15%)
receiving antiresorptive agents and 6 cases (5%) receiving
anabolic agents. Moreover, Rojanasthienet al. reported that
only 4.2% of the post-hip fracture patients received anti-
resorptive agents [14]. This indicates that inadequate treatment
is from both the high cost of therapy and poor awareness of
physicians. In Thailand, the cost of antiresorptive drugs is at
approximately 800 USD/patient/year and for anabolic drug the
cost is approximately 9,400 USD/patient/year. Whencompared to the gross yearly income of most Thai patients,
these drugs are at a very high cost. Poor physician awareness
is shown by a study that demonstrated that several surgeons
did not see the important of osteoporotic drugs and did not
have a proper understanding of calcium and vitamin D sup-
plements. They also did not recommend the proper exercise
and activity or fall prevention.
This study showed some limitations with the population
size. A small number of patients were observed and a larger
sample size is required to determine other possible associated
risk factors in the Thai population. The study population was
mostly Asian patients, therefore the findings might not
generalizable to other ethnic groups. There were other con-
founding risk factors in each individual, such as comorbidity
and general health status for which the data were not included
in the study due to limitations of data collection.
5. Conclusion
This study shows that the one-year mortality rate of oste-
oporotic hip fracture patients 50 years of age was 9%.
However the rate is increased after an osteoporotic hip frac-
ture, especially within the first year post-fracture, where the
rate was about 3.3 times higher when compared to the general
population in the same age range (9.2% vs 2.28%). Higher
mortality rates were only associated with a non-operative
treatment. Patients who were treated non-operatively had a
mortality risk 3.93 times higher than those who were treated
operatively (23.8% vs 6.1%).
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